Jungbunzlauer closes acquisition of Illinois facility to launch U.S. manufacturing operations
– Strategic investment enhances service to North American customers and supports rising…
Jungbunzlauer Tricalcium Citrate Excipient Demonstrates Outstanding Results in Direct Compression Study
- New research confirms Jungbunzlauer's TCC TB supports efficient, high-quality tablet manufacturing…
PSMAddition data show Novartis Pluvicto delays progression to end-stage prostate cancer
Basel, October 19, 2025 – Novartis today presents new Pluvictoâ„¢ (lutetium (177Lu)…
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving…
Artprice News: ahead of Frieze London and Art Basel Paris, Artprice by Artmarket releases its 2025 Contemporary Art Market Report. Annual record number of auction transactions, substantial market paradigm shift, AI influences
PARIS, Oct. 7, 2025 /PRNewswire/ -- With Frieze London about to kick…
Jungbunzlauer to acquire from International Flavors & Fragrances, Inc. multipurpose site in Thomson, IL
 – establishing U.S. manufacturing footprint – BASEL, Switzerland, Sept. 2, 2025 /PRNewswire/…
Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules…
Ascensia Launches Global Art Competition Exploring the Link Between Diabetes and Anxiety
Fourth annual initiative supports World Diabetes Day 2025 with patient-led creativity and…
Roche receives CE Mark for minimally invasive blood test to help rule out Alzheimers disease
Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test…
BioVersys and Shionogi Enter Into Global Research Collaboration For Broad-Spectrum Non-Tuberculous Mycobacteria (NTM) Clinical Candidate
July 02, 2025 01:00 ET Â | Source: BioVersys Ad hoc announcement pursuant…